Trial Details

COMPLETED
Basic Information
Clinical ID c4591
Identifier NCT00280956
Trial Title Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: natalizumab
Participant Information
Sponsor Biogen
City San Diego
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2002-07
Primary Completion Date 2004-09
Completion Date 2004-09